Morgan Stanley’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.3M Buy
1,064,015
+46,471
+5% +$1.87M ﹤0.01% 2203
2025
Q4
$38.1M Buy
1,017,544
+292,530
+40% +$9.81M ﹤0.01% 2349
2025
Q3
$21.4M Sell
725,014
-388,307
-35% -$9.03M ﹤0.01% 2820
2025
Q2
$26.3M Buy
1,113,321
+342,191
+44% +$7.14M ﹤0.01% 2541
2025
Q1
$13.9M Sell
771,130
-508,442
-40% -$9.98M ﹤0.01% 3046
2024
Q4
$21.8M Buy
1,279,572
+164,601
+15% +$2.85M ﹤0.01% 2667
2024
Q3
$16.4M Buy
1,114,971
+44,157
+4% +$553K ﹤0.01% 2992
2024
Q2
$12.2M Buy
1,070,814
+709,922
+197% +$7.75M ﹤0.01% 3163
2024
Q1
$3.92M Buy
+360,892
New +$3.61M ﹤0.01% 4106

Other funds holding BTSG

Morgan Stanley's BTSG Position: Q1 2026 in Review

Morgan Stanley increased its BrightSpring Health Services (BTSG) stake by 4.6% in Q1 2026, buying an estimated $1.87M and bringing the position to 1,064,015 shares worth $45.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

Morgan Stanley first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • Morgan Stanley held 1,064,015 shares of BrightSpring Health Services worth $45.3M as of Q1 2026.
  • Morgan Stanley bought 46,471 BrightSpring Health Services shares in Q1 2026, an estimated $1.87M.
  • BrightSpring Health Services made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2203 holding.
  • Morgan Stanley first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.